Abstract:Primary pericardial mesothelioma is an extremely rare and lethal cardiac tumor. We report an autopsy case of a primary pericardial mesothelioma in a 52-year-old man. He developed dyspnea, cough, low-grade fever and night sweats approximately 3 months before last admission. Initially, he was evaluated at a hospital in another city, without a firm diagnosis. Due to progressive symptoms and the development of lower-extremity edema, he presented at our hospital in September 2005. The physical examination at admiss… Show more
“…One of the largest autopsy series including about 500,000 cases gave an incidence of primary pericardial tumours of <0.0022% (Gossinger et al, 1998). However, it accounts for approximately 2-3% of all cardiac and pericardial primary tumours being the third tumour after angiosarcoma and rhabdomiosarcoma (Karadzic et al, 2005;Papi et al, 2005).…”
Section: Epidemiologymentioning
confidence: 99%
“…The most common sites for this malignancy include the pleura (60-70%) and the peritoneum (30-35%). Primary pericardial mesothelioma accounts for only about 1% of all mesotheliomas (Karadzic et al, 2005;Papi et al, 2005).…”
Section: Epidemiologymentioning
confidence: 99%
“…Metastases are present in about 25-45% of the patients and involve regional lymph nodes, lung and kidney (Karadzic et al, 2005;Lagrotteria et al, 2005).…”
“…One of the largest autopsy series including about 500,000 cases gave an incidence of primary pericardial tumours of <0.0022% (Gossinger et al, 1998). However, it accounts for approximately 2-3% of all cardiac and pericardial primary tumours being the third tumour after angiosarcoma and rhabdomiosarcoma (Karadzic et al, 2005;Papi et al, 2005).…”
Section: Epidemiologymentioning
confidence: 99%
“…The most common sites for this malignancy include the pleura (60-70%) and the peritoneum (30-35%). Primary pericardial mesothelioma accounts for only about 1% of all mesotheliomas (Karadzic et al, 2005;Papi et al, 2005).…”
Section: Epidemiologymentioning
confidence: 99%
“…Metastases are present in about 25-45% of the patients and involve regional lymph nodes, lung and kidney (Karadzic et al, 2005;Lagrotteria et al, 2005).…”
“…In an epidemiological survey, the incidence of PMPM was estimated to be 0.0022% (5). Making an antemortem diagnosis of PMPM is challenging and misdiagnosis is common (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14). We encountered a case radiologically presenting with an anterior mediastinal mass and pericardial nodules, mimicking an anterior mediastinal tumor.…”
Primary malignant pericardial mesothelioma is an exceptionally rare tumor, and making an antemortem diagnosis of this disease is notoriously difficult. We herein report the case of a 61-year-old woman with pericardial mesothelioma who presented with shortness of breath and peripheral edema of the lower limbs. Chest computed tomography (CT) showed an anterior mass and thickened pericardium with multiple pericardial nodules. A biopsy of the mediastinal mass was performed using right thoracotomy, and the histological findings indicated a sarcomatoid tumor. The patient was treated with chemotherapy; however, she but died three months after diagnosis. An autopsy confirmed a final diagnosis of sarcomatoid type primary malignant pericardial mesothelioma following extensive immunohistopathological examinations.
“…ПМТП локализуется в перикарде, но в результате злокачественного инвазивного ро-ста может инфильтрировать в эпикард и миокард желудочков и предсердий, коронарные синусы, коронарные артерии, проводящую систему серд-ца, распространяться на восходящую аорту или легочный ствол; метастазы в региональные лимфа-тические узлы и отдаленные метастазы выявляются у 25-40% больных [4,5]. Гистологически мезотели-омы гетерогенны, традиционно выделяют эпите-лиоидный, саркоматозный, десмопластический и бифазный варианты [6,7].…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations –citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.